Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex VirusSeptember 24, 2025 7:00 AM EDT | Source: Theralase Technologies Inc.Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, bacteria and viruses, announced today the peer-rev ...